SUBSCRIBERS

Corporate digest

Published Fri, Oct 28, 2016 · 09:50 PM

Tianjin Zhong Xin Pharma

TIANJIN Zhong Xin Pharmaceutical Group Corp saw net profit for the third quarter ended Sept 30 slide 6 per cent year on year to 89.32 million yuan (S$18.4 million).

Meanwhile, revenue for the three-month period fell 10 per cent to 1.49 billion yuan. However, gross profit rose 9 per cent to 473.15 million yuan as cost of sales came down 17 per cent to 1.02 billion yuan. Earnings per share came to 0.12 yuan, down from 0.13 yuan a year ago.

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Companies & Markets

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here